SU628930A1 - Device for introducing medicinal powders - Google Patents
Device for introducing medicinal powdersInfo
- Publication number
- SU628930A1 SU628930A1 SU742097190A SU2097190A SU628930A1 SU 628930 A1 SU628930 A1 SU 628930A1 SU 742097190 A SU742097190 A SU 742097190A SU 2097190 A SU2097190 A SU 2097190A SU 628930 A1 SU628930 A1 SU 628930A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- medicinal powders
- introducing medicinal
- introducing
- powders
- cavity
- Prior art date
Links
Description
При практическом использовании устройства уровень порошка а емкости е превышает половины длины цек;гральной трубки. .Подсоединение емкости с лекарственным препаратом к игле производ т при сжатой груше , что обеспечивает в первой фазе работы засасывание воздуха нз каверны в емкость дл лекарственного пред рата, а при второй фазе (сжатии) порошок, увлекаемый тем же объемом eosjGiyxa, выталкиваетс в каверну .In practical use of the device, the level of powder and capacity e exceeds half the length of the grinding tube. .Connecting the drug container to the needle is performed with a compressed pear, which ensures that in the first phase of the operation air is drawn from the cavity into the container for the medicinal product, and during the second phase (compression) the powder carried along by the same volume of eosjGiyxa is pushed into the cavity.
Описанное устройство обеспечивает введ ние лекарственного препарата в атологнческую полость с использованием мнниMaJibHoro объема воздуха дл устранени перераст женн стенок полости.The described device provides for the introduction of a medicament into the atrial cavity using a plurality of air volume to eliminate the overgrowth of the cavity walls.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU742097190A SU628930A1 (en) | 1974-11-26 | 1974-11-26 | Device for introducing medicinal powders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU742097190A SU628930A1 (en) | 1974-11-26 | 1974-11-26 | Device for introducing medicinal powders |
Publications (1)
Publication Number | Publication Date |
---|---|
SU628930A1 true SU628930A1 (en) | 1978-10-25 |
Family
ID=20607598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU742097190A SU628930A1 (en) | 1974-11-26 | 1974-11-26 | Device for introducing medicinal powders |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU628930A1 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5740794A (en) * | 1994-09-21 | 1998-04-21 | Inhale Therapeutic Systems | Apparatus and methods for dispersing dry powder medicaments |
US5780014A (en) * | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
US6089228A (en) * | 1994-09-21 | 2000-07-18 | Inhale Therapeutic Systems | Apparatus and methods for dispersing dry powder medicaments |
US6679256B2 (en) | 1999-12-17 | 2004-01-20 | Nektar Therapeutics | Systems and methods for extracting powders from receptacles |
US6681767B1 (en) | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
WO2006088894A2 (en) | 2005-02-15 | 2006-08-24 | Elan Pharma International Limited | Aerosol and injectable formulations of nanoparticulate benzodiazepine |
EP2263652A1 (en) | 1998-11-12 | 2010-12-22 | Elan Pharma International Limited | Aerosols comprising nanoparticle drugs |
US8161969B2 (en) | 1998-06-04 | 2012-04-24 | Novartis Ag | Dry powder dispersing apparatus and methods for their use |
WO2012106382A1 (en) | 2011-01-31 | 2012-08-09 | Genoa Pharmaceuticals, Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
US8357696B2 (en) | 2005-05-18 | 2013-01-22 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
EP2594272A2 (en) | 2005-05-18 | 2013-05-22 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US8629139B2 (en) | 2008-10-07 | 2014-01-14 | Mpex Pharmaceuticals, Inc. | Topical use of Levofloxacin for reducing lung inflammation |
US8815838B2 (en) | 2008-10-07 | 2014-08-26 | David C. Griffith | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US9700529B2 (en) | 2002-05-03 | 2017-07-11 | Nektar Therapeutics | Particulate materials |
US9700564B2 (en) | 2009-09-04 | 2017-07-11 | Horizon Orphan Llc | Use of aerosolized levofloxacin for treating cystic fibrosis |
-
1974
- 1974-11-26 SU SU742097190A patent/SU628930A1/en active
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6681767B1 (en) | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
US5785049A (en) * | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
US6089228A (en) * | 1994-09-21 | 2000-07-18 | Inhale Therapeutic Systems | Apparatus and methods for dispersing dry powder medicaments |
US5740794A (en) * | 1994-09-21 | 1998-04-21 | Inhale Therapeutic Systems | Apparatus and methods for dispersing dry powder medicaments |
US5780014A (en) * | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
US5993783A (en) * | 1995-04-14 | 1999-11-30 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder α1-antitrypsin |
US8161969B2 (en) | 1998-06-04 | 2012-04-24 | Novartis Ag | Dry powder dispersing apparatus and methods for their use |
EP2263652A1 (en) | 1998-11-12 | 2010-12-22 | Elan Pharma International Limited | Aerosols comprising nanoparticle drugs |
US6679256B2 (en) | 1999-12-17 | 2004-01-20 | Nektar Therapeutics | Systems and methods for extracting powders from receptacles |
US10188614B2 (en) | 2002-05-03 | 2019-01-29 | Nektar Therapeutics | Particulate materials |
US10945972B2 (en) | 2002-05-03 | 2021-03-16 | Nektar Therapeutics | Particulate materials |
US9700529B2 (en) | 2002-05-03 | 2017-07-11 | Nektar Therapeutics | Particulate materials |
EP2353590A1 (en) | 2005-02-15 | 2011-08-10 | Elan Pharma International Limited | Aerosol and injectable formulations of nanoparticulate benzodiazepine |
WO2006088894A2 (en) | 2005-02-15 | 2006-08-24 | Elan Pharma International Limited | Aerosol and injectable formulations of nanoparticulate benzodiazepine |
US8524735B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
EP2594272A2 (en) | 2005-05-18 | 2013-05-22 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US8546423B2 (en) | 2005-05-18 | 2013-10-01 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US10987357B2 (en) | 2005-05-18 | 2021-04-27 | Horizon Orphan, LLC | Aerosolized fluoroquinolones and uses thereof |
US8357696B2 (en) | 2005-05-18 | 2013-01-22 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US8524734B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US10149854B2 (en) | 2008-10-07 | 2018-12-11 | Horizon Orphan Llc | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US9717738B2 (en) | 2008-10-07 | 2017-08-01 | Horizon Orphan Llc | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US9326936B2 (en) | 2008-10-07 | 2016-05-03 | Raptor Pharmaceuticals, Inc. | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US8815838B2 (en) | 2008-10-07 | 2014-08-26 | David C. Griffith | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US10722519B2 (en) | 2008-10-07 | 2020-07-28 | Horizon Orphan Llc | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US8629139B2 (en) | 2008-10-07 | 2014-01-14 | Mpex Pharmaceuticals, Inc. | Topical use of Levofloxacin for reducing lung inflammation |
US11020481B2 (en) | 2008-10-07 | 2021-06-01 | Horizon Orphan Llc | Topical use of levofloxacin for reducing lung inflammation |
US9700564B2 (en) | 2009-09-04 | 2017-07-11 | Horizon Orphan Llc | Use of aerosolized levofloxacin for treating cystic fibrosis |
US10231975B2 (en) | 2009-09-04 | 2019-03-19 | Horizon Orphan Llc | Use of aerosolized levofloxacin for treating cystic fibrosis |
US10792289B2 (en) | 2009-09-04 | 2020-10-06 | Horizon Orphan Llc | Use of aerosolized levofloxacin for treating cystic fibrosis |
WO2012106382A1 (en) | 2011-01-31 | 2012-08-09 | Genoa Pharmaceuticals, Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
EP4059499A1 (en) | 2011-01-31 | 2022-09-21 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU628930A1 (en) | Device for introducing medicinal powders | |
BE860727A (en) | NEW TRANS-N- (2-AMINOCYCLOALIPHATIC) BENZAMIDES, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM | |
FR2353290A1 (en) | NEW PROSTAGLANDIN ANALOGUES, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM | |
BE827127A (en) | NEW DERIVATIVES OF OXY-16 PROSTANOIC ACID, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC USE | |
IE45048L (en) | Syringe. | |
GB1335797A (en) | Multiple dosage inoculator | |
FR2273522A2 (en) | NEW ALCANOLAMINE DERIVATIVE, ITS PREPARATION PROCESS AND MEDICINAL PRODUCT CONTAINING IT | |
BE827777A (en) | NEW CARBOXYLIC ACID AMIDS, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM | |
FR2274294A1 (en) | NEW CARBOXYLIC ACID AMIDS, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM | |
ZA752067B (en) | Process for preparing a pharmaceutical preparation containing zinc-zn suitable for medical use | |
BE829052A (en) | NEW SUBSTITUTES PHENYLGUANIDINES, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM | |
FR2276048A1 (en) | NEW CYCLOHEXANOL ESTERS, THEIR SALTS, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM | |
BE848310A (en) | DI ACIDS (2 PHENOXY-CARBOXYL ALKANES), THEIR PREPARATION PROCESS AND THEIR USE AS MEDICINAL PRODUCTS | |
BE794414A (en) | NEW AMINO-ALCOHOLS, THEIR PREPARATION AND THEIR APPLICATION AS A MEDICINAL PRODUCT | |
Merson | Numerical integration of the differential equations of celestial mechanics | |
BE786713A (en) | NEW AMINO-ALCOHOLS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
FR2346005A1 (en) | NEW LACTONS OF FREE ACIDS OF THE PROSTAGLANDIN TYPE, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM | |
BE831421A (en) | NEW SUBSTITUTED PHENYLISOTHIOUREES, THEIR PROCESS OF PREPARATION AND THE MEDICINAL PRODUCT CONTAINING THEM | |
BE861697A (en) | NEW POLYCYCLIC ANTIBIOTICS, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM | |
IT1085297B (en) | PYRAZOL-PYRIMIDINYL (TION) (TIOL) -PHOSPHORIC (PHOSPHONIC) ESTERS, PROCEDURE FOR THEIR PREPARATION AND USE WITH INSECTICIDES AND ACARICIDES | |
NL7507422A (en) | PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH BLOOD PRESSURE-LOWERING ACTION, SUCH MEDICINAL PRODUCT AND A PROCESS FOR PREPARING THE ACTIVE COMPOUNDS. | |
CA1029305A (en) | Infusion solution for the treatment of tachycardiac disturbances of heart rhythm and use thereof | |
ES436179A1 (en) | Physiological substances for intensifying the pharmacological effect of drugs | |
FR2291758A1 (en) | NEW BENZODIAZEPINES, THEIR PREPARATION AND THE MEDICINAL PRODUCT CONTAINING THEM | |
JPS5356317A (en) | Preparation of capsulated drug, and capsules and trays preparig the same |